• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC141000
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 02/11/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient medical history includes but is not limited to: aaa, hypertension, cabg, congestive heart failure.The instructions for use (ifu) for the gore® excluder® aaa endoprosthesis states, adverse events that may occur and / or require intervention include but are not limited to: dilatation, endoleak.
 
Event or Problem Description
On (b)(6) 2018, this patient underwent endovascular treatment for an abdominal aortic aneurysm and was implanted with gore® gore® excluder® aaa endoprostheses featuring c3® delivery system.The patient tolerated the procedure.On (b)(6) 2022, the patient underwent follow-up computed tomography angiography wherein the physician identified a type 1b endoleak was present in the right common iliac artery (rcia) and decided to treat it.The physician decided to coil embolize the right internal iliac artery (riia) and extend the original device in the right common iliac artery (rcia).A contralateral leg component was implanted to extend coverage down to the right external iliac artery with intentional coverage of the riia.The distal endoleak was noted to have been due to disease progression distal to the original device.The endoleak resolved, and the patient tolerated the procedure well.Patient is reported to be doing fine.
 
Additional Manufacturer Narrative
H6: code 213: a review of the manufacturing records for the device(s) verified that the lot(s) met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY B/P
2890 de la cruz blvd.
santa clara CA 95050
Manufacturer Contact
laura crawford
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13742890
Report Number3013164176-2022-01329
Device Sequence Number4607480
Product Code MIH
UDI-Device Identifier00733132618637
UDI-Public00733132618637
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/14/2021
Device Model NumberPLC141000
Device Catalogue NumberPLC141000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/11/2022
Supplement Date Received by Manufacturer03/11/2022
Initial Report FDA Received Date03/12/2022
Supplement Report FDA Received Date03/15/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/15/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Hospitalization; Required Intervention;
Patient SexFemale
Patient Weight57 KG
-
-